Home›Stock Screener›Nath Bio-Genes›Quarterly Results

Nath Bio-Genes Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹5 Cr
QSept 2025
Quarterly Results

In Sept 2025, Nath Bio-Genes (NATHBIOGEN) reported revenue ₹48 Cr and net profit ₹5 Cr — revenue +50.0% YoY. For annual financials, live price and key ratios, visit NATHBIOGEN share price.

NATHBIOGEN Quarterly Results — Revenue, Profit & EPS Highlights

Nath Bio-Genes latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View NATHBIOGEN annual price range for the annual high/low range and current price position.

  • Revenue of ₹48 Cr in Sept 2025 (-14.3% vs Mar 2025, +50.0% vs Sept 2024)
  • Net Profit of ₹5 Cr in Sept 2025 (+150.0% vs Mar 2025, +400.0% vs Sept 2024)
  • EBITDA of ₹10 Cr in Sept 2025 (+100.0% vs Mar 2025)
  • Operating Margin of 14.0% in Sept 2025 (+13.0pp vs Mar 2025)
  • Earnings Per Share of ₹2.53 in Sept 2025 (+502.4% vs Mar 2025)

Nath Bio-Genes Quarterly Results — Revenue, EBITDA, Net Profit & EPS

NATHBIOGEN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 48 56 288 70 32 -14.3% 50.0%
Net Profit (₹ Cr) 5 2 37 2 1 - -
EBITDA (₹ Cr) 10 5 42 8 5 - -
EPS (₹) 2.53 0.42 19.58 0.84 0.53 - -
Operating Margin (%) 14.0% 1.0% 13.0% 5.0% 15.0% - -

NATHBIOGEN Share Price Trend — 1-Year Movement Across Quarterly Results

Nath Bio-Genes 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices.

Profitability Ratios

Profit Margin 10.4%
EBITDA Margin 20.8%
Operating Margin 14.0%
ROE (Annual) 3.1%

Balance Sheet Highlights

Total Assets ₹1,026 Cr
Total Equity ₹644 Cr
Current Assets ₹690 Cr
Current Liabilities ₹17 Cr

Cash Flow Analysis

Operating Cash Flow ₹18 Cr
Investing Cash Flow ₹-4 Cr
Financing Cash Flow ₹-2 Cr
Net Cash Flow ₹12 Cr

Current Market Data

Current Price ₹196.01
Exchange NSE
Last Updated Apr 30, 2026

Revenue Trend (₹ Cr)

Dec 2025 70
Jun 2025 288
Mar 2025 56
Sept 2025 48

Net Profit Trend (₹ Cr)

Dec 2025 2
Jun 2025 37
Mar 2025 2
Sept 2025 5

Operating Margin Trend (%)

Dec 2025 5.0%
Jun 2025 13.0%
Mar 2025 1.0%
Sept 2025 14.0%

NATHBIOGEN vs FMCG Peers — Quarterly Revenue, Profit & Market Cap

Nath Bio-Genes latest quarter revenue and net profit vs FMCG competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Hindustan Unilever
Sept 2025 		₹546,820.37 Cr 2250.9 16,108 2,694 +2.2% - 16.7% 196.9
ITC
Sept 2025 		₹377,881.56 Cr 314.9 20,032 5,187 -41.0% - 25.9% 77.0
Marico
Sept 2025 		₹102,164.02 Cr 775.0 3,531 432 +27.2% - 12.2% 239.2
Patanjali Foods
Sept 2025 		₹49,840.61 Cr 459.5 9,828 517 +0.9% - 5.3% 96.7
AWL Agri Business
Mar 2026 		₹25,889.60 Cr 196.4 21,623 293 +23.4% +18.2% 1.4% 86.9
Sector Quarterly Performance Comparison
FMCG sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores